| |
Be informed: Educational teleconferences about living with relapsing MS
|
|
|
|
| |
|
CALL IN |
Join our informative nationwide programs hosted by leading MS experts. One number for all: 1-800-823-1880. Call today to set up a reminder call, or simply call in on the night you choose to participate. No reservation required.
UPCOMING NATIONAL TELECONFERENCES
Injection Tips for Healthier Skin
A small change can make a big difference
|
September 23, 2014 - 8:00 PM ET | September 24, 2014 - 9:00 PM ET |
| |
|
Speaker: Suzanne Alterman, CNE |
Shared Solutions® Update
Building on our experiences with enhanced offerings
|
October 21, 2014 - 8:00 PM ET | October 22, 2014 - 9:00 PM ET |
| |
|
Speaker: Sandy Searcy, Shared Solutions® Nurse |
Stress Management
Take a deep breath...
|
November 18, 2014 - 8:00 PM ET | November 19, 2014 - 9:00 PM ET |
| |
|
Speakers: Emily Riser, MD, with Larissa Nusser, Patient Advocate |
Year in Review
Reflecting on your past goals and setting new ones
|
December 9, 2014 - 8:00 PM ET | December 10, 2014 - 9:00 PM ET |
| |
|
Speaker: Randall Trudell, MD |
For support or additional information, please call Shared Solutions®
at 1-800-887-8100, or visit www.COPAXONE.com
|
|
|
|
| |
COPAXONE® is indicated for the treatment of patients with relapsing forms of multiple sclerosis.
Important Safety Information
Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol.
Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.
Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.
A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.
The most common side effects in studies of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information.
Privacy Notice | One Click Unsubscribe | Terms of Use
|
|
| |
|
|
| |
|
|
COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd.
Shared Solutions® is a registered service mark of Teva Neuroscience, Inc.
© 2014 Teva Neuroscience, Inc. COP-42074
Teva Neuroscience, Inc., COPAXONE® Marketing,
11100 Nall Avenue, Overland Park, KS 66211
|
|
|